ScoreWhy is Fischer Medical Ventures Ltd ?
1
Poor Management Efficiency with a low ROE of 1.39%
- The company has been able to generate a Return on Equity (avg) of 1.39% signifying low profitability per unit of shareholders funds
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
With a growth in Net Sales of 268.22%, the company declared Outstanding results in Sep 25
- The company has declared positive results for the last 2 consecutive quarters
- OPERATING PROFIT TO NET SALES(Q) Highest at 18.84%
- NET SALES(Q) Highest at Rs 86.31 cr
- PBDIT(Q) Highest at Rs 16.26 cr.
4
With ROE of 0.4, it has a Very Expensive valuation with a 8.4 Price to Book Value
- Over the past year, while the stock has generated a return of -26.16%, its profits have fallen by -20%
5
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
6
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 2.07% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -26.16% returns
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Fischer Medical should be less than 10%
- Overall Portfolio exposure to Commodity Chemicals should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Commodity Chemicals)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Fischer Medical for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Fischer Medical
-26.3%
-0.47
55.44%
Sensex
4.78%
0.40
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
427.60%
EBIT Growth (5y)
0.60%
EBIT to Interest (avg)
1.69
Debt to EBITDA (avg)
9.13
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
0.27
Tax Ratio
37.27%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
6.99%
ROCE (avg)
1.92%
ROE (avg)
1.39%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
2063
Industry P/E
40
Price to Book Value
8.43
EV to EBIT
1787.28
EV to EBITDA
909.79
EV to Capital Employed
8.70
EV to Sales
27.29
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.49%
ROE (Latest)
0.41%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend37What is working for the Company
OPERATING PROFIT TO NET SALES(Q)
Highest at 18.84%
NET SALES(Q)
Highest at Rs 86.31 cr
PBDIT(Q)
Highest at Rs 16.26 cr.
PBT LESS OI(Q)
Highest at Rs 14.82 cr.
PAT(Q)
Highest at Rs 13.93 cr.
EPS(Q)
Highest at Rs 2.14
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Fischer Medical
Net Sales - Quarterly
At Rs 86.31 cr has Grown at 178.4% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 31.01 CrMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 14.82 cr has Grown at 1226.2% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 1.12 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 13.93 cr has Grown at 743.2% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 1.65 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 18.84% and Grown
each quarter in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Net Sales - Quarterly
Highest at Rs 86.31 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 16.26 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 14.82 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 13.93 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 2.14
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
